Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease
Abstract
Share and Cite
Liczek, M.; Panek, I.; Damiański, P.; Jęczeń, O.; Jaźwiec, J.; Kuna, P.; Panek, M. Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Adv. Respir. Med. 2018, 86, 183-191. https://doi.org/10.5603/ARM.a2018.0028
Liczek M, Panek I, Damiański P, Jęczeń O, Jaźwiec J, Kuna P, Panek M. Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Advances in Respiratory Medicine. 2018; 86(4):183-191. https://doi.org/10.5603/ARM.a2018.0028
Chicago/Turabian StyleLiczek, Maciej, Iga Panek, Piotr Damiański, Olga Jęczeń, Jędrzej Jaźwiec, Piotr Kuna, and Michał Panek. 2018. "Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease" Advances in Respiratory Medicine 86, no. 4: 183-191. https://doi.org/10.5603/ARM.a2018.0028